Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12349777 | 0.92 | CETP (0.42) | IDO1L3MBTL1SIGMAR1CHRM2HTR1A | |
| SCHEMBL12349721 | 0.90 | LTA4H (0.43) | IDO1L3MBTL1MEN1KMT2AADRA1A | |
| SCHEMBL18389767 | 0.88 | TDP1 (0.43) | IDO1KCNH2AOC3HTR2A | |
| SCHEMBL17232216 | 0.87 | SIGMAR1 (0.41) | IDO1L3MBTL1SIGMAR1MAOAMAOB | |
| SCHEMBL13616969 | 0.86 | CETP (0.38) | IDO1L3MBTL1SIGMAR1CHRM2HTR1A | |
| SCHEMBL12349748 | 0.85 | LTA4H (0.39) | IDO1KMT2AADRA1ASLC6A3 | |
| SCHEMBL18979042 | 0.85 | IDO1 (0.47) | IDO1L3MBTL1MEN1KMT2ASIGMAR1 | |
| SCHEMBL12349723 | 0.84 | IDO1 (0.38) | IDO1L3MBTL1MEN1KMT2ASIGMAR1 | |
| SCHEMBL1068905 | 0.82 | IDO1 (0.44) | IDO1L3MBTL1MEN1KMT2ASIGMAR1 | |
| SCHEMBL12349713 | 0.81 | TDP1 (0.38) | IDO1KCNH2AOC3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170166594-A1 | Organosilicon modified photoinitiator and a photo-curable adhesive composition comprising the same | HENKEL (CHINA) COMPANY LIMITED (CN) | 2017-06-15 | — | — | US | disclosed |
| WO-2016029439-A1 | ORGANOSILICON MODIFIED PHOTOINITIATOR AND PHOTO-CURABLE ADHESIVE COMPOSITION THEREOF | HENKEL (CHINA) COMPANY LIMITED (CN) | 2016-03-03 | — | — | WO | disclosed |
| US-8049024-B2 | Heterogenized rhodium complexes, methods of their synthesis and application as hydrosilylation catalysts | ADAM MICKIEWICZ UNIVERSITY (PL) | 2011-11-01 | — | — | US | disclosed |
| US-20100048932-A1 | New Heterogenized Rhodium Complexes, Methods of their Synthesis and Application as Hydrosilylation Catalysts | ADAM MICKIEWICZ UNIVERSITY (PL) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048932-A1 | New Heterogenized Rhodium Complexes, Methods of their Synthesis and Application as Hydrosilylation Catalysts | SQLE, HAO2, IPO11 | IDO1 79/4885L3MBTL1 4346/4885MEN1 2115/4885 |
| US-20170166594-A1 | Organosilicon modified photoinitiator and a photo-curable adhesive composition comprising the same | ITGB2, ITGB8, C3AR1 | IDO1 1193/4885L3MBTL1 332/4885MEN1 2329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.